Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Oppelt

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Oral Oncology|August 31, 2025
Management of HPV+ head and neck squamous cell carcinoma with unknown primary in the era of treatment de-escalationThomas F Barrett, Anthony J Apicelli, Salma Ramadan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2025
Contralateral Neck Recurrence Rates After Ipsilateral Neck Adjuvant Radiation in Head and Neck Carcinomas with a Pathologically Negative Contralateral NeckKendall J Kiser, Anthony J Apicelli, Randall J Brenneman, et al.
Oral Oncology|February 11, 2021
Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trialDouglas R Adkins, Jin-Ching Lin, Assuntina Sacco, et al.
BMC Pregnancy and Childbirth|August 2, 2023
Predicting adverse outcomes in pregnant patients positive for SARS-CoV-2: a machine learning approach- a retrospective cohort studyDylan Young, Bita Houshmand, Chunyi Christie Tan, et al.
Der Gynakologe|March 24, 2021
[COVID-19 and pregnancy]Helmut Kleinwechter, Tanja Groten, Ute Schäfer-Graf, et al.
Journal of Cancer Survivorship : Research and Practice|April 17, 2024
Trends in ototoxicity monitoring among cisplatin-treated patients with cancerDavid S Lee, Emma Y Travis, Susan K Wong, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 5, 2020
Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral SurgeryStephanie Y Chen, Parul Sinha, Aisling Last, et al.
The Lancet. Oncology|May 14, 2021
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialAssuntina G Sacco, Ruifeng Chen, Francis P Worden, et al.
Journal of Medical Genetics|February 1, 2011
High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasiaSerena Nik-Zainal, Reiner Strick, Mekayla Storer, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 1, 2025
Long-Term Outcomes of Patients With HPV+ Unknown Primary Squamous Cell Carcinoma Treated With Transoral SurgeryThomas F Barrett, Adam Boukind, Kwasi Enin, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Oral Oncology|August 31, 2025
Management of HPV+ head and neck squamous cell carcinoma with unknown primary in the era of treatment de-escalationThomas F Barrett, Anthony J Apicelli, Salma Ramadan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2025
Contralateral Neck Recurrence Rates After Ipsilateral Neck Adjuvant Radiation in Head and Neck Carcinomas with a Pathologically Negative Contralateral NeckKendall J Kiser, Anthony J Apicelli, Randall J Brenneman, et al.
Oral Oncology|February 11, 2021
Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trialDouglas R Adkins, Jin-Ching Lin, Assuntina Sacco, et al.
BMC Pregnancy and Childbirth|August 2, 2023
Predicting adverse outcomes in pregnant patients positive for SARS-CoV-2: a machine learning approach- a retrospective cohort studyDylan Young, Bita Houshmand, Chunyi Christie Tan, et al.
Der Gynakologe|March 24, 2021
[COVID-19 and pregnancy]Helmut Kleinwechter, Tanja Groten, Ute Schäfer-Graf, et al.
Journal of Cancer Survivorship : Research and Practice|April 17, 2024
Trends in ototoxicity monitoring among cisplatin-treated patients with cancerDavid S Lee, Emma Y Travis, Susan K Wong, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 5, 2020
Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral SurgeryStephanie Y Chen, Parul Sinha, Aisling Last, et al.
The Lancet. Oncology|May 14, 2021
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialAssuntina G Sacco, Ruifeng Chen, Francis P Worden, et al.
Journal of Medical Genetics|February 1, 2011
High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasiaSerena Nik-Zainal, Reiner Strick, Mekayla Storer, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 1, 2025
Long-Term Outcomes of Patients With HPV+ Unknown Primary Squamous Cell Carcinoma Treated With Transoral SurgeryThomas F Barrett, Adam Boukind, Kwasi Enin, et al.
Pageof 18